Gene · 1660
Papers2,696
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,696
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation. | Nat Struct Mol Biol | 2023 | 37957306 | PubTator, text mining | PubMed |
| AL360181.1 promotes proliferation and invasion in colon cancer and is one of ten m6A-related lncRNAs that predict overall survival. | PeerJ | 2023 | 37953780 | PubTator, text mining | PubMed |
| TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. | Nucleic Acids Res | 2023 | 37953292 | PubTator, text mining | PubMed |
| Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37953273 | PubTator, text mining | PubMed |
| MS2 Virus-like Particles as a Versatile Peptide Presentation Platform: Insights into the Deterministic Abilities for Accommodating Heterologous Peptide Lengths. | ACS Synth Biol | 2023 | 37946498 | PubTator, text mining | PubMed |
| Understanding nucleic acid sensing and its therapeutic applications. | Exp Mol Med | 2023 | 37945923 | PubTator, text mining | PubMed |
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. | Front Immunol | 2023 | 37928532 | PubTator, text mining | PubMed |
| Elevated high-mannose N-glycans hamper endometrial decidualization. | iScience | 2023 | 37915610 | PubTator, text mining | PubMed |
| Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. | Exp Mol Med | 2023 | 37907737 | PubTator, text mining | PubMed |
| Antigen presentation by B cells enables epitope spreading across an MHC barrier. | Nat Commun | 2023 | 37907556 | PubTator, text mining | PubMed |
| Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway. | J Immunother Cancer | 2023 | 37907220 | PubTator, text mining | PubMed |
| IDO1 facilitates esophageal carcinoma progression by driving the direct binding of NF-κB and CXCL10. | Cell Death Discov | 2023 | 37903782 | PubTator, text mining | PubMed |
| The Small-Molecule E26-Transformation-Specific Inhibitor TK216 Attenuates the Oncogenic Properties of Pediatric Leukemia. | Genes (Basel) | 2023 | 37895265 | PubTator, text mining | PubMed |
| R-Loops in Genome Instability and Cancer. | Cancers (Basel) | 2023 | 37894353 | PubTator, text mining | PubMed |
| Cell-Permeable Stimuli-Responsive Ubiquitin Probe for Time-Resolved Monitoring of Substrate Ubiquitination in Live Cells. | JACS Au | 2023 | 37885572 | PubTator, text mining | PubMed |
| Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy. | RNA Biol | 2023 | 37882652 | PubTator, text mining | PubMed |
| Crystal structures of the DExH-box RNA helicase DHX9. | Acta Crystallogr D Struct Biol | 2023 | 37860960 | PubTator, text mining | PubMed |
| m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer. | Transl Cancer Res | 2023 | 37859733 | PubTator, text mining | PubMed |
| TCA cycle tailoring facilitates optimal growth of proton-pumping NADH dehydrogenase-dependent Escherichia coli. | Microbiol Spectr | 2023 | 37855642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1660/papers?page=11